Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy-Reference-Cited by-同舟云学术

Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy

Published:2017-11 Issue:46 Volume:96 Page:e8696
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Huang Chao-Min,Hu Tsung-Hui,Chang Kuo-Chin,Tseng Po-Lin,Lu Sheng-Nan,Chen Chien-Hung,Wang Jing-Houng,Lee Chuan-Mo,Tsai Ming-Chao,Lin Ming-Tsung,Yen Yi-Hao,Hung Chao-Hung,Cho Chung-Lung,Wu Cheng-Kun

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference36 articles.

1. Metaanalysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 update;Thevenot;J Viral Hepat,2001

2. Outcome of sustained virological responders with histologically advanced chronic hepatitis C;Morgan;Hepatology,2010

3. Eradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studies;Morgan;Ann Intern Med,2013

4. Dynamic α-fetoprotein, platelets and AST-to-Platelet Ratio Index predict hepatocellular carcinoma in chronic hepatitis C patients with sustained virological response after antiviral therapy;Wu;J Antimicrob Chemother,2016

5. Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C;Poynard;J Hepatol,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VFMAP predicted hepatocellular carcinoma development in patients with chronic hepatitis C who were treated with direct-acting antiviral and achieved sustained virologic response;Journal of Medical Ultrasonics;2023-12-26

2. Liver injury indicators and subsequent cancer development among non‐fatty liver population;Cancer Medicine;2023-04-04

3. Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma;World Journal of Hepatology;2022-06-27

4. Serum α‐fetoprotein level at treatment completion is a useful predictor of hepatocellular carcinoma occurrence more than one year after hepatitis C virus eradication by direct‐acting antiviral treatment;Journal of Viral Hepatitis;2021-10-27

5. 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population;Journal of the Formosan Medical Association;2020-06